Compare ACIW & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACIW | ITGR |
|---|---|---|
| Founded | 1975 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 2.6B |
| IPO Year | 1995 | 2000 |
| Metric | ACIW | ITGR |
|---|---|---|
| Price | $48.50 | $79.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | $60.00 | ★ $93.71 |
| AVG Volume (30 Days) | ★ 701.7K | 556.3K |
| Earning Date | 11-06-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.89 | N/A |
| EPS | ★ 2.47 | 2.42 |
| Revenue | $1,731,220,000.00 | ★ $1,831,074,000.00 |
| Revenue This Year | $11.40 | $9.58 |
| Revenue Next Year | $1.46 | N/A |
| P/E Ratio | ★ $19.48 | $30.57 |
| Revenue Growth | 7.01 | ★ 9.54 |
| 52 Week Low | $40.45 | $62.00 |
| 52 Week High | $58.14 | $146.36 |
| Indicator | ACIW | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 58.14 | 68.14 |
| Support Level | $46.53 | $72.17 |
| Resistance Level | $48.87 | $73.49 |
| Average True Range (ATR) | 1.09 | 1.95 |
| MACD | 0.35 | 1.32 |
| Stochastic Oscillator | 92.57 | 87.57 |
ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The company also develops batteries used in nonmedical applications in the energy, military, and environmental markets. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns more than half of its revenue in the United States.